Entecavir to TAF Switch

• Status: Active, not recruiting
• Trial end date: 2020-09-16

Summary

A research study to observe the safety, efficacy and tolerability of switching from Entecavir (ETV) to Tenofovir Alafenamide TAF in patients with chronic hepatitis B

• Phase: Phase 3

Details

• Lead Sponsor: Thomas Jefferson University
• Collaborator: Gilead Sciences
• Treatments: Entecavir; Tenofovir